Sylvie Gregoire

Filings by Sylvie Gregoire span 2 companies, the busiest being Revvity, Inc. and CervoMed Inc. In total, 28 filings cover trades dated from 10 May 2016 to 17 November 2025.

In open-market terms, that means 6 purchases worth €243k on one side and 2 sales worth €1.2M on the other. Sales outweigh purchases by €994k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 17 share grants and 2 option exercises. So far in 2025, the count stands at 6 purchases and no sales.

A typical purchase (the median) is worth €32k. 6 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

On 19 November 2025 came the latest disclosure, an open-market purchase for €79k in CervoMed Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.